Biopharmaceuticals are drugs developed through the application of biotechnology on living organisms intended for the treatment of diseases. These are generally obtained by genetically manipulating the genes that are responsible for the occurrence of a particular disease. ( http://www.bharatbook.com/detail.asp?id=149802&rt=Biopharmaceuticals.html )
* Indian biopharmaceuticals market is primarily generic with a majority of the Indian companies supplying vaccines (preventive and therapeutic), and a few selling biosimilars in the semi-regulated market.
* Indian players are expected to tap the impending biosimilars opportunity in the regulated market while retaining a stable foothold in the semi-regulated market.
Key chapters :
Sections
Key highlights 1
Segmental definition 2
Structure 4
- Industry structure 4
- Market size and structure 5
- Growth drivers of the industry 6
- Revenue model 8
- Cost structure 11
- Industry structure 11
- Porters five competitive forces model 12
- Regulatory environment 13
- Drug development process 16
Conduct 19
- Player Profiles 19
Performance 29
- Demand Review 29
- Demand outlook 29
- Cost and margins 30
- Financial performance 31
Investment opportunity 32
- Opportunities and risks 32
- Risks and structural weaknesses 33
- Investments and financing 33
- Mergers and acquisition 34
- Glossary 35
- Fact Sheet 35
Boxes
Structure 4
- Key elements of the National Biotechnology Development Strategy 16
Performance 29
- Indian biopharmaceutical market Demand methodology 30
For more information kindly visit : http://www.bharatbook.com/detail.asp?id=149802&rt=Biopharmaceuticals.html
Related Reports
Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline